Friday April 03, Barcelona

01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Meeting room 131‑132
Transgender therapy and relationship with bone disorders
Chairperson: ‣ Bruno Muzzi Camargos
‣ Guidelines for hormonal therapy on transgender patients Ariana Sierra Osorio
‣ From man to woman and from woman to man: Does it matter? Andres Coy
‣ Densitometric acquisition, analysis and reporting Bruno Muzzi Camargos
‣ Recommendations to maintain bone health on transgender patients Adriana Medina Orjuella
Meeting room 127‑128
Vitamin D deficiency and rheumatic diseases
Chairperson: ‣ Panagiotis Athanassiou
‣ Vitamin D deficiency and autoimmunity Ifigenia Kostoglou‑Athanassiou
‣ Vitamin D deficiency and rheumatoid arthritis Yannis Dionyssiotis
‣ Vitamin D deficiency and systemic lupus erythematosus Panagiotis Athanassiou
‣ Vitamin D receptor polymorphisms and autoimmune diseases Lambros Athanassiou
Meeting room 133‑134
Global Impact of Bone Health TeleECHO: The Prototype for Technology Enabled Collaborative Learning for Skeletal Healthcare
Chairperson: ‣ E. Michael Lewiecki
‣ Introduction and Background of Bone Health TeleECHO E. Michael Lewiecki
‣ National University of Ireland Galway Bone Health TeleECHO John J. Carey
‣ Bone Health TeleECHO Moscow Zhanna Belaya
‣ Rare Bone Disease TeleECHO Kassim Javaid
‣ Panel discussion with all faculty
Meeting room 118
Artificial Intelligence (AI) in Musculoskeletal Imaging – A Paradigm Shift ‘ante portas’?
Chairperson: ‣ Hans Peter Dimai
‣ Principles of deep learning and machine learning John A. Carrino
‣ AI in various modalities of musculoskeletal imaging (radiography, DXA, CT, MRT) Ronald M. Summers
‣ Knee osteoarthritis assessment by AI increases physicians’ agreement rate and accuracy Stefan Nehrer
Meeting room 119
Managing fracture risk in primary care: roles and requirements
Chairperson: ‣ Zoe Paskins
‣ Current challenges for primary care osteoporosis management Zoe Paskins
‣ What osteoporosis care looks like in current UK general practice Elizabeth Cottrell
‣ Primary care and the management of special groups at risk of fracture Elizabeth Cottrell
‣ How primary care osteoporosis management can be improved John Edwards
‣ Summing up: Challenges and opportunities for better integration of primary and secondary care Zoe Paskins
‣ Close Zoe Paskins
Meeting room 120
Nationwide identification of vertebral fragility fractures: Collaborating with Radiology
Chairperson: ‣ Bo Abrahamsen
‣ Collaboration for better patient outcomes in vertebral fracture Jill Griffin
‣ National audit on the reporting of incidentally found vertebral fractures in routine radiology practice Nadia Mahmood
‣ Evaluation of the identification of vertebral fractures within fracture liaison services- looking to the future Kassim Javaid
‣ Evaluating the demand on fracture liaison services with effective identification of vertebral fractures Helen Glenn
Meeting room 121
Winning the political case for change – launch of a policy toolkit for osteoporosis and fragility fractures
Chairperson: ‣ Ed Harding
‣ Welcome and introduction to the project Ed Harding
‣ Critical challenges in osteoporosis and fragility fracture care Cyrus Cooper
‣ Policy actions needed to improve prevention and care of osteoporosis and fragility fractures John Bowis
‣ Next steps for the network Ed Harding
‣ Discussion and wrap-up Ed Harding
Meeting room 122
Targeting bone and muscle: Novel therapeutic approaches to osteosarcopenia
Chairperson: ‣ Serge Ferrari
‣ RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass from mice to humans Nicolas Bonnet
‣ Old and new roles of amino acids and amino butyric acids in musculoskeletal diseases Marco Brotto
‣ Fat as a therapeutic target in osteosarcopenia Gustavo Duque
Meeting room 123
Joint Symposium of the IOF Skeletal Rare Diseases Working Group (SRD-WG) and the a European Reference Network on Rare Bone Diseases (ERN-BOND)
Chairperson: ‣ Maria Luisa Brandi
‣ Diversity on the pathophysiology of increased bone fragility in rare bone diseases Naveen Hamdy
‣ Quality of bone in Osteogenesis Imperfecta patients Luca Sangiorgi
08.00 - 09.00
Meeting room 124‑125
Gut microbiota (GMB) and osteoarthritis (OA) management: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing.
Chairpersons: ‣ Islene Araujo de Carvalho, ‣ Sansin Tüzün, ‣ Francis Berenbaum
‣ Introduction Emmanuel Biver
‣ Gut microbiota and inflammation Claudio Franceschi
‣ Role of gut microbiota in non-communicable disease and osteoarthritis management Emmanuel Biver
‣ Discussion Francis Berenbaum
Panel: ‣ Islene Araujo de Carvalho, ‣ Francis Berenbaum, ‣ Emmanuel Biver, ‣ Maria Luisa Brandi, ‣ Philip Calder, ‣ Vincenzo Castronovo, ‣ Etienne Cavalier, ‣ Antonio Cherubini, ‣ Elaine M. Dennison, ‣ Claudio Franceschi, ‣ Nicholas R. Fuggle, ‣ Andrea Laslop, ‣ Pierre Miossec, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Thierry Thomas, ‣ Sansin Tüzün, ‣ Nicola Veronese
09.00 - 10.30
Auditorium A
SCIENTIFIC SESSION I
Chairpersons: ‣ Cyrus Cooper, ‣ René Rizzoli
09.00
Auditorium A
Plenary Lecture 1
‣ Transient treatment discontinuation : pros and cons Michael R. McClung
09.30
Auditorium A
Oral communication selected from abstracts
10.30 - 12.10
Auditorium A
SCIENTIFIC SESSION II
Chairpersons: ‣ Jean‑Yves Reginster, ‣ John A. Kanis
10.30
Auditorium A
Presentation of the ESCEO-IOF Herbert Fleisch Medal
‣ René Rizzoli
10.35
Auditorium A
Presentation of the IOF President's Award
‣ Cyrus Cooper
10.40
Auditorium A
Plenary Lecture 2
‣ Differences in clinical guidelines Eugene McCloskey
11.10
Auditorium A
Oral communication selected from abstracts
12.00
Auditorium A
Presentation of the ESCEO-AgNovos Healthcare Young Investigator Awards
‣ Jean‑Yves Reginster
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Meeting room 131‑132
Discussion of complex osteoporotic cases
‣ Adolfo Diez‑Perez
Meeting room 133‑134
Management of CKD-MBD
‣ Jorge Cannata Andia
Meeting room 118
Nutritional approach of osteoporosis prevention
‣ Stefania Maggi
Meeting room 119
GIOP : what to do ?
‣ Emmanuel Biver
Meeting room 120
Pharmacoepidemiology of musculoskeletal disease
‣ Daniel Prieto‑Alhambra
14.00 - 15.00
Meeting room 124‑125
Alternative treatments for osteoarthritis: stem cells, platelet-rich plasma, autologous chondrocyte transplantation, ...: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: ‣ Willem Lems, ‣ Francis Berenbaum
‣ Introduction and scope of the problem Emmanuel Maheu
‣ Role of surgical regenerative therapies in the management of knee osteoarthritis Richard Oreffo
‣ Role of "alternative" treatments of knee osteoarthritis Nicholas R. Fuggle
‣ Discussion Jean‑François Kaux
Panel: ‣ Francis Berenbaum, ‣ Jaime Branco, ‣ Maria Luisa Brandi, ‣ Olivier Bruyère, ‣ Philip Conaghan, ‣ Cyrus Cooper, ‣ Bernard Cortet, ‣ Maurizio Cutolo, ‣ Nicholas R. Fuggle, ‣ Germain Honvo, ‣ Jean‑François Kaux, ‣ Willem Lems, ‣ Emmanuel Maheu, ‣ Radmila Matijevic, ‣ Richard Oreffo, ‣ Andrew Price, ‣ Jean‑Yves Reginster, ‣ Roland Roth, ‣ Thierry Thomas, ‣ Nicola Veronese
14.00 - 15.00
Meeting room 127‑128
Is there a role for MHT in the management of post-menopausal osteoporosis? Outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: ‣ Maria Luisa Brandi, ‣ Tim Hillard
‣ Welcome and scope of the problem Antonio Cano
‣ Effects of MHT on bone: What, when, how? Florence Trémollières
‣ Risk/benefit ratio of MHT before and after 60 years Giuseppe Rosano
‣ Discussion (Leader: Serge Rozenberg): All participants of the Working Group
‣ Conclusions Antonio Cano
Panel: ‣ Mylène Aubertin‑Leheudre, ‣ Maria Luisa Brandi, ‣ Antonio Cano, ‣ Peter Collins, ‣ Cyrus Cooper, ‣ Andrea Genazzani, ‣ Nicholas Harvey, ‣ Tim Hillard, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Irene Lambrinoudaki, ‣ Andrea Laslop, ‣ Daniel Prieto‑Alhambra, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Giuseppe Rosano, ‣ Serge Rozenberg, ‣ Florence Trémollières
14.00 - 15.00
Poster Area
Poster Viewing Session I
14.00 - 15.03
Podium
Oral presentation of selected posters
15.00 - 17.00
Auditorium A
SCIENTIFIC SESSION III
Chairpersons: ‣ Nicholas Harvey, ‣ Bess Dawson‑Hughes
15.00
Auditorium A
Plenary Lecture 3
‣ Bone turnover markers in clinical practice Etienne Cavalier
15.30
Auditorium A
Oral communication selected from abstracts
16.30
Auditorium A
Plenary Lecture 4
‣ Bone fragility: beyond bone loss Serge Ferrari
15.00 - 16.45
Meeting room 127‑128
COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION
‣ Musculoskeletal diseases: diagnosis, management and consequences
Chairpersons: ‣ Philippe Halbout, ‣ Jean‑Yves Reginster, ‣ Famida Jiwa
15.45
Meeting room 127‑128
Presentation of the IOF Committee of National Societies Medal
‣ Jean‑Yves Reginster